<DOC>
	<DOC>NCT00212628</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.</brief_summary>
	<brief_title>Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>1. Patients who was included in study ONO592002 and completed the medication for two years 2. Other inclusion criteria as specified in the study protocol 1. Patients judged to be unsuitable by safety evaluation as clinical trial subjects by the investigator 2. Patients having secondary osteoporosis or another condition that presents low bone mass 3. Other exclusion criteria as specified in the study protocol</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-5920</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>bisphosphonate</keyword>
</DOC>